Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Costco Wholesale Corporation (COST) vs DexCom, Inc. (DXCM) Price & Performance

Costco Wholesale CorporationTrade
DexCom, Inc.Trade

Price performance (Past 24H)

Key statistics

Costco Wholesale Corporation vs DexCom, Inc. — how do they compare? Costco Wholesale Corporation trades at $946.8 (market cap $420.05B), while DexCom, Inc. trades at $83.42 (market cap $31.86B). The key difference: Costco Wholesale Corporation is far larger — about 13.2× DexCom, Inc.'s market cap, and Costco Wholesale Corporation pays a 0.62% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Costco Wholesale Corporation for 133 Days and DexCom, Inc. for 62 Days on average.

COSTDXCM
Market Cap
$420.05B$31.86B
Volume
2,087,5653,607,070
Sector
Consumer StaplesHealth
52-Week High
$1.09K$92.34
52-Week Low
$849.63$54.84
Typical Hold Time
133 Days62 Days
Enterprise Value
$407.33B$31.32B
Dividend Yield
0.62%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Costco Wholesale Corporation

COST trades at $944.20, up 0.21% on the day, with a bullish technical signal from moving averages but overbought RSI readings. The company reported strong March 2026 sales growth of 11.3% year-over-year (Costco Wholesale Corporation, April 8, 2026) and has shown consistent revenue and net income growth, with fiscal 2025 revenue at $275.24B and net income at $8.10B. Analyst consensus is strongly bullish with a $1,100 price target, though valuation ratios like a P/E of 45.66 are elevated.

The outlook remains positive due to robust membership fee growth and expansion, but risks include high valuation sensitivity and competitive pressures. Upside is supported by strong institutional buying and earnings beats, though any market pullback could pressure the stock given its premium multiples.

DexCom, Inc.

DexCom (DXCM) trades at $84.03, down 0.32% on the day, with strong fundamental performance including three consecutive quarterly EPS beats and robust 20.12% net income margin. The stock shows bearish technical signals with price near pivot point support at $84, while analyst consensus remains overwhelmingly positive with 81% buy ratings and $95.07 price target representing 13% upside potential. Recent news highlights expansion opportunities in Type 2 diabetes care and executive promotions.

DXCM presents a compelling growth story with expanding profit margins and consistent earnings outperformance, though technical weakness and premium valuation create near-term headwinds. The company's leadership in continuous glucose monitoring and Type 2 diabetes market expansion provide long-term catalysts, while competition and reimbursement risks require monitoring.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

COST
31% Buy69% Sell
Avg holding period · 133 Days
DXCM
100% Buy0% Sell
Avg holding period · 62 Days

Top news

Latest headlines on both assets

About Costco Wholesale Corporation

The leading warehouse club, Costco has 815 stores worldwide (at the end of fiscal 2021), with most sales derived in the United States (72%) and Canada (14%). It sells memberships that allow customers to shop in its warehouses, which feature low prices on a limited product assortment. Costco mainly caters to individual shoppers, but roughly 20% of paid members carry business memberships. Food and sundries accounted for 40% of fiscal 2021 sales, with non-food merchandise 29%, warehouse ancillary and other businesses (such as fuel and pharmacy) nearly 17%, and fresh food 14%. Costco's warehouses average around 146,000 square feet

Read more on COST →

About DexCom, Inc.

Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.

Read more on DXCM →